Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 7/20 | 0.45 |
| ▸ | BCHE | P06276 | 3/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.42 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23721994 | 0.99 | ACHE (0.44) | ACHEBCHEMTNR1AMTNR1BCHRM4 | |
| SCHEMBL23745452 | 0.90 | BCHE (0.42) | ACHEBCHEROCK2MAPT | |
| Hydrochloric Acid SCHEMBL22439438 | 0.89 | BCHE (0.42) | ACHEBCHEROCK2MAPT | |
| SCHEMBL23745692 | 0.84 | LMNA (0.42) | ACHEBCHEMAPT | |
| Hydrochloric Acid SCHEMBL23721860 | 0.83 | LMNA (0.41) | ACHEBCHEMAPT | |
| SCHEMBL23745498 | 0.83 | MTNR1A (0.45) | ACHEBCHEMTNR1AMTNR1BPLA2G2A | |
| Hydrochloric Acid SCHEMBL23721926 | 0.82 | MTNR1A (0.45) | ACHEMTNR1AMTNR1BPLA2G2AMAPT | |
| SCHEMBL23745756 | 0.82 | USP2 (0.42) | MAPT | |
| SCHEMBL23745526 | 0.82 | ITGB3 (0.38) | ACHEBCHEROCK2MAPT | |
| SCHEMBL23745574 | 0.81 | ICMT (0.40) | ACHEBCHEROCK2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | FDPS, FPR1, F12 | ACHE 813/4885BCHE 953/4885MTNR1A 4020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.